Leukotriene receptor antagonist therapy.

O J Dempsey

Journal: Postgraduate medical journal 2001;76(902):767-73

PMID: 11085767

Free Full Text on PubMed Central View on PubMed

Abstract

Leukotriene receptor antagonists (LTRA) are a new class of drugs for asthma treatment, available in tablet form. Their unique mechanism of action results in a combination of both bronchodilator and anti-inflammatory effects. While their optimal place in asthma management is still under review, LTRA represent an important advance in asthma pharmacotherapy.

Address: Asthma and Allergy Research Group, Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.

DOI: 10.1136/pmj.76.902.767

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/asthma.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Acetates, Anti-Asthmatic Agents, Asthma, Asthma, Exercise-Induced, Chronic Disease, Cyclopropanes, Humans, Indoles, Leukotriene Antagonists, Phenylcarbamates, Quinolines, Sulfides, Sulfonamides, Tosyl Compounds